<?xml version="1.0" encoding="UTF-8"?>
<p>Our research team has also recently presented a group of heterocyclic compounds containing a β-amino acid motif presenting different biological activities, and their potential therapeutic usefulness has been evaluated as well [
 <xref rid="B17-molecules-26-00438" ref-type="bibr">17</xref>]. The MZO-2 compound, an isoxazole β-amino acid derivative, suppressed LPS (lipopolysaccharide)-induced production of TNF α (tumor necrosis factor α) [
 <xref rid="B18-molecules-26-00438" ref-type="bibr">18</xref>].
</p>
